pseudomembranous colitis

Fecal microbiota transplantation as a treatment option for patients with recurrent Clostridioides difficile-associated diarrhea

Clinical Microbiology and Antimicrobial Chemotherapy. 2022; 24(4):308-313

10.36488/cmac.2022.4.308-313

This paper provides a review of the largest studies (over the period of 2017 to 2022) on the use of fecal microbiota transplantation (FMT) for the treatment of patients with recurrent *Clostridioides difficile*associated diarrhea (CDAD), including …

Importance of Appropriate Rapid Diagnosis of C. difficile in Limited Resource Settings

Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(1):30-33

With the ever present threat of healthcare-associated infections such as C. difficile, are we at increased risk of outbreaks whilst resources to decontaminate wards and isolate patients are? Article explores the importance of rapid diagnosis of C. …

Current Understanding of Clostridium difficile Infection

Clinical Microbiology and Antimicrobial Chemotherapy. 2002; 4(3):200-232

At the present time Clostridium difficile is the main causative pathogen of nosocomial diarrhea, that linked to the use of antimicrobials. But at the same time there is an unjustified little attantion paid to this problem in Russia. In the present …

Antibiotic-Associated Diarrhea

Clinical Microbiology and Antimicrobial Chemotherapy. 2002; 4(1):22-32

Diarrhea, which is associated with the usage of antimicrobials, is one of the important problems in clinical practice. This article reviews the questions of etiology, pathogenesis and epidemiology of antibiotic-associated diarrhea (AAD). Clinical …